The Pharma Data

JANUARY 31, 2021

Clover plans to initiate a global Phase 2/3 efficacy trial of its protein-based S-Trimer COVID-19 vaccine candidate adjuvanted with Dynavax’s CpG 1018 plus alum in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021. EMERYVILLE, Calif. and CHENGDU, China , Feb.

Vaccination 52

Vaccination Vaccine Trials Protein 52

Drug Discovery World

JANUARY 9, 2023

Harvard investigators have developed a new cell therapy approach to eliminate established tumours and induce long-term immunity. . Using gene engineering, we are repurposing cancer cells to develop a therapeutic that kills tumour cells and stimulates the immune system to both destroy primary tumors and prevent cancer.” .

Scientist 52

Scientist Gene Editing Gene Engineer 52

The Pharma Data

MAY 7, 2021

Johnson & Johnson COVID-19 Vaccinations Resume Following CDC and FDA Decision. Mathai Mammen, Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 9:40 a.m. See more information and instructions on how to setup the tag on: [link] >. Skip to content.

Branding 52

Branding Vaccination Vaccine Development 52

World of DTC Marketing

SEPTEMBER 9, 2021

If pharma is a business, they will find a way to develop, buy, or acquire new drugs. New technologies are being developed that allow for virtual clinical trials and other cost-lowering development costs. Then there is the cost of people who refuse to get vaccinated against COVID.

Drugs 222

Drugs Pharmacy Clinical Trials Clinical Trials 222

Rethinking Clinical Trials

OCTOBER 26, 2023

There are possible clinical research components that would include research on treatment during pregnancy, vaccine development, and implementation model research. A manuscript is under development. Discussions are currently underway with 13 partner sites.

Clinical Research 141

Clinical Research Clinical Trials Clinical Trials Research 141

Drug Discovery World

JULY 25, 2023

DDW recently hosted Where are the breakthroughs in mRNA drug discovery and development? In this webinar, sponsored by Elegen, attendees learnt about the breakthroughs in mRNA drug discovery and development. We have shown that the excipient does not only work for our SNAP-tag lipid (SNaP) LNP, but also for the commercialised vaccines.

Drugs 52

Drugs Packaging Packaging Manufacturing 52

Pharmaceutical Technology

MAY 15, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. The company develops drugs and diagnostics to treat major diseases.

Antibody 130

Antibody DNA Development Vaccination 130

Delveinsight

FEBRUARY 23, 2021

The company develops transformative biologics including vaccines and therapeutics for the world’s most debilitating diseases. The company plans to use the capital to expand its pipeline of protein-based vaccines and biologic cancer therapies utilizing its innovative and proprietary Trimer-Tag technology platform.

In-Vitro 52

In-Vitro Vaccination Vaccine Licensing 52

pharmaphorum

DECEMBER 23, 2022

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives. As inobrodib also has an effect on the androgen receptor pathway, with potential in prostate cancer, also.

Development 52

Development Drugs Clinical Development Antibody 52

pharmaphorum

SEPTEMBER 15, 2020

“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. As part of this, a number of big pharma companies are also racing to develop a safe and effective vaccine for the coronavirus.

Branding 130

Branding Marketing Pharma Companies Life Science 130

pharmaphorum

JANUARY 21, 2022

Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model.

Medicine 52

Medicine Marketing Manufacturing Production 52

pharmaphorum

JANUARY 31, 2023

With the recent rapid rollout of Covid-19 vaccines, many people have raised questions about whether adequate research was conducted on these vaccines before approval. Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Vaccination 52

pharmaphorum

NOVEMBER 27, 2022

Instead, companies should be looking towards a future where speed and agility are the key components in developing business resilience, rather than a reliance on inventory stockpiles and large quality assured batches. Automation will be a large part of this long-term vision.

Production 105

Production Manufacturing Drugs Marketing 105

pharmaphorum

NOVEMBER 19, 2021

The race to find and bring vaccines to market to fight Covid was impressive. It’s been almost a year since the first Covid vaccine was authorised for use. The mRNA jab, developed by Pfizer and BioNTech, launched to huge fanfare in December 2020 and promised the start of the end of the coronavirus pandemic.

Sales 137

Sales Vaccination Vaccine Marketing 137

pharmaphorum

DECEMBER 2, 2020

It was a success, and set the pattern for the company’s future development. Also, when supply of tartaric acid was disrupted due to the civil war and increased tariffs, Pfizer developed its production to become the leading supplier of chemicals in the US. Pfizer’s Tokyo building. The era of mega-mergers.

Sales 128

Sales Production Drugs Marketing 128

XTalks

APRIL 6, 2021

Where flour, pasta and other shelf-stable goods once sat in abundance quickly emptied to nothing but price tags. Technology has been at the forefront of many aspects of COVID-19 relief, from treatments and vaccines to how we communicate and work with one another from a distance. The same went for meat and dairy.

Production 104

Production Sales Vaccination Vaccine 104

The Pharma Data

NOVEMBER 15, 2020

. Cytiva provides FlexFactory bioprocessing upstream and downstream solutions for Clover to accelerate GMP facility development and shorten time to market. In addition, this will meet Clover’s Phase 2/3 clinical production plan and commercial readiness once its vaccine candidate is approved. SHANGHAI , Nov.

Vaccination 52

Vaccination Vaccine Manufacturing Life Science 52

XTalks

AUGUST 17, 2020

Immunotherapy continues to be a burgeoning field, with immune-based therapies being among the leading treatments being developed in oncology and autoimmunity. protein-based biologics) and vaccine treatments. Treatment vaccines : these boost the immune system responses to target cells. Immune system modulators (i.e.

Protein 98

Protein Engineer Immune Response In-Vivo 98

Drug Discovery World

NOVEMBER 13, 2023

On Day 3, Thursday 16 November 2023, the tracks include: the second part of machine learning for protein engineering, antibodies against membrane protein targets, engineering bispecific antibodies, next-generation immunotherapies, protein stability and formulation, and protein process development.

Protein 59

Protein Antibody Engineer Scientist 59

XTalks

MARCH 22, 2023

Our webinars have become a key vendor-selection tool for decision-makers across the drug development pipeline — from discovery to commercialization — which is why all ten of the top ten contract research organizations (CROs) have worked with Xtalks. Click on the infographic to explore the data.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

pharmaphorum

JUNE 15, 2021

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. However, New Science is more expensive to develop. billion and $6.7

Clinical Trials 90

Clinical Trials Clinical Trials Development Marketing 90

pharmaphorum

FEBRUARY 26, 2021

However, it wasn’t until 1959 – 73 years and two major acquisitions later – that J&J developed its significant presence in the pharmaceutical industry. Cordis was founded in Miami in 1959 and develops and produces medical equipment to treat patients who suffer from cardiovascular disease. Where it all began.

Sales 126

Sales Production Pharma Companies Marketing 126

Intouch Solutions

JULY 27, 2021

” they pointed out that the COVID-19 vaccines, and the controversial approval of aducanumab for the treatment of Alzheimer’s disease, represented polar opposites in terms of drug pricing reform. In the case of the vaccines, the U.S. government lowered risk by supporting trials, guaranteeing contracts, and negotiating a lower price.

Drugs 52

Drugs Marketing Vaccination Vaccine 52

Delveinsight

DECEMBER 3, 2020

The company anticipates the test can aid in tracking the success of vaccines and recognize people who have recovered from infection and could serve as convalescent plasma donors or help in the development of new therapies. An overactivity of complement damages cells in the macula in geographic atrophy.

Gene Therapy 52

Gene Therapy Gene Antibody Research 52

The Pharma Data

MARCH 20, 2021

use and development of proteomic methods to. effective SARS-CoV-2 vaccine continues to attract. L volumes, even for notoriously difficult liquid classes like the 100% acetonitrile used to store the Tandem Mass Tags (TMT). Highlight #3 Professor Ed Emmott is the leader of. The lab’s goal is the. As the race for an.

Reagent 52

Reagent RNA Bioinformatics Medicine 52

The Pharma Data

MAY 4, 2021

to $3.65, Primarily Reflecting Updates to Anticipated Contributions from BNT162b2 Partially Offset by Additional R&D Expenses for Vaccines to Protect Against COVID-19 as Well as Other mRNA-Based Development Programs and COVID-19 Antivirals. Raises Full-Year 2021 Guidance (3) for Revenues to a Range of $70.5 Adjusted Income (2).

Vaccination 40

Vaccination Vaccine Production Sales 40

World of DTC Marketing

JUNE 16, 2021

The pharma industry has been riding a wave of public approval since they developed a vaccine to fight COVID-19, but that goodwill is going to be short lived thanks, in part, to the $56,000 price tag of Biogen’s new drug and insulin that too many people still can’t afford.

Drugs 180

Drugs Branding Medicine Insulin 180